Is Moderna Finally Ready To Make A ‘Big Commitment’ On Not-For-Profit COVID-19 Vaccines?

Last Company To Pledge

 
• By Andrew McConaghie

Some countries want an IP waiver to boost access to vaccines, but industry leaders say this will do nothing to increase output.

Covax
The COVAX facility aims to distribute 2 billion doses in 2021, but so far has only shipped 40.5 million.

Moderna could be close to making a long-awaited pledge to supply its COVID-19 vaccine to developing world nations via a not-for-profit deal.

That is according to the company’s CEO Stephane Bancel, who has said the company’s negotiations with the COVAX facility are now in the “final stretch”

More from Business

More from Scrip